Status:
UNKNOWN
Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults
Lead Sponsor:
University Hospital of Cologne
Collaborating Sponsors:
Clinic for Internal Medicine I, University Hospital Cologne, Germany
Institute of Virology, University Hospital Cologne, Germany
Conditions:
COVID-19
SARS-CoV-2
Eligibility:
All Genders
Brief Summary
The investigators aim to characterise Coronavirus Disease 2019 (COVID-19) in every age group. On the one hand, emphasis is put on the initial presentation, clinical course, outcome and the therapy use...
Detailed Description
In 2019 the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the pathogen causing the Coronavirus Disease 2019 (COVID-19) pandemic. Many retrospective s...
Eligibility Criteria
Inclusion
- patients with COVID-19: detection of SARS-CoV-2 by PCR in naso- or oropharyngeal swab or sputum, no age limit
- control group: any respiratory tract infection not caused by SARS-CoV-2, no age limit
- informed consent
Exclusion
- no respiratory tract infection and no detection of SARS-CoV-2
- no informed consent
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2020
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04341168
Start Date
April 1 2020
End Date
October 1 2020
Last Update
April 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Cologne
Cologne, North Rhine-Westphalia, Germany, 50937